Terumo (OTCMKTS:TRUMY) Sees Strong Trading Volume - Here's What Happened

Key Points

• Terumo Corp. experienced a significant increase in trading volume, with 287,438 shares traded on a recent day, up 85% from the previous session.
• The company reported a Q2 earnings per share of $0.20, exceeding analysts' expectations, although revenue reached $1.76 billion, slightly below the $1.80 billion estimate.
• Terumo has a solid financial standing with a debt-to-equity ratio of 0.07 and a market cap of approximately $25.91 billion.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) saw unusually-strong trading volume on Monday . Approximately 287,438 shares were traded during mid-day trading, an increase of 85% from the previous session's volume of 155,541 shares.The stock last traded at $17.50 and had previously closed at $17.44.

Terumo Price Performance

The firm has a market capitalization of $24.59 billion, a PE ratio of 29.14 and a beta of 0.79. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.53 and a current ratio of 2.64. The business's 50 day moving average is $17.62 and its two-hundred day moving average is $18.18.

Terumo (OTCMKTS:TRUMY - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Terumo had a net margin of 12.09% and a return on equity of 9.19%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.80 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.